Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Energy Fuels Aktie: Achtung, Aufholpotenzial! (Aktiencheck) +++ ENERGY FUELS Aktie -3,11%

BIOMARK DIAGNOSTICS Aktie

>Performance
1 Woche: 0%
1 Monat: +8,2%
3 Monate: +24,2%
6 Monate: +68,2%
1 Jahr: +13,1%
laufendes Jahr: +66,7%
>BIOMARK DIAGNOSTICS Aktie
Name:  BIOMARK DIAGNOSTICS INC.
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA09073K1084 / A12EKB
Symbol/ Ticker:  20B (Frankfurt)
Kürzel:  FRA:20B, ETR:20B, 20B:GR
Index:  -
Webseite:  https://www.biomarkdiagno..
Marktkapitalisierung:  18.44 Mio. EUR
Umsatz:  0.13 Mio. EUR
EBITDA:  -1.65 Mio. EUR
Gewinn je Aktie:  -0.009 EUR
Schulden:  1.29 Mio. EUR
Liquide Mittel:  0.08 Mio. EUR
Umsatz-/ Gewinnwachstum:  -7.2% / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  160.43 / - / -
Gewinnm./ Eigenkapitalr.:  - / -
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  BIOMARK DIAGNOSTICS, BIOMARK DIAGNOSTIC
Letzte Datenerhebung:  04.07.25
>Eigentümer
Aktien: 90.89 Mio. St.
f.h. Aktien: 46.41 Mio. St.
Insider Eigner: 44.36%
Instit. Eigner: -
Leerverk. Aktien: -
>Peer Group

 
20.05.25 - 14:42
 BioMark Diagnostics, Inc.: BioMark Diagnostics Announces Breakthrough Publication Reinforcing Leadership in AI-Powered Metabolomics for Oncology (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - May 20, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leader in developing liquid biopsy tests for early cance......
12.05.25 - 14:42
 BioMark Diagnostics, Inc.: BioMark Diagnostics Announces Landmark Publication Validating High Specificity and Accuracy of Its Early-Stage Lung Cancer Test (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy tests for early cance......
08.05.25 - 14:51
 BioMark Diagnostics announces uplisting to OTCQB venture market (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
08.05.25 - 14:43
 BioMark Diagnostics, Inc.: BioMark Diagnostics Announces Uplisting to OTCQB Venture Market (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - May 8, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (OTCQB: BMKDF) (FSE: 20B) ("BioMark" or the "Company"), a leading developer of liquid biopsy tests......
31.03.25 - 14:42
 BioMark Diagnostics, Inc.: BioMark Announces the Final Closing of Oversubscribed Private Placement (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - March 31, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a leading developer of liquid biopsy tests for early ......
26.03.25 - 13:48
 BioMark Diagnostics, Inc.: BioMark Secures Financing for Initial Tranche to Advance Early-Detection Oncology Testing Platform (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - March 26, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) ("BioMark"), a leading developer of liquid biopsy tests for early cancer detection, ......
28.02.25 - 14:42
 BioMark Diagnostics, Inc.: BioMark Diagnostics Underscores Commitment to Rare Disease Research on Rare Disease Day 2025 (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - February 28, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a leading developer of liquid biopsy tests for ear......
10.12.24 - 14:42
 BioMark Diagnostics, Inc.: BioMark′s Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered ER Status Prediction (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - December 10, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a leader in liquid biopsy tests for early cancer d......
05.11.24 - 14:42
 BioMark Diagnostics, Inc.: BioMark Expands Its Liquid Biopsy Platform with Two Groundbreaking Publications in Breast Cancer Detection (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - November 5, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) ("BioMark"), a leading developer of liquid biopsy tests for early......
24.09.24 - 14:42
 BioMark Diagnostics, Inc.: BioMark Diagnostics and Principal Investigators Publish an Important Approach Using Metabolomics and ML to Identify Biomarkers for NEN (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - September 24, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF), a leading developer of liquid biopsy tests for early cancer d......
10.09.24 - 14:42
 BioMark Diagnostics, Inc.: BioMark Diagnostics Completes Testing of over 5,400 Subjects as Part of a Validation Study for Early Lung Cancer Detection (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - September 10, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF), a leading developer of liquid biopsy tests for early cancer d......
26.08.24 - 14:42
 BioMark Diagnostics, Inc.: Biomark Diagnostics to Showcase Innovative Liquid Biopsy Technology at H.C. Wainwright′s 26th Annual Global Investment Conference in New York (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - August 26, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF), a leading developer of liquid biopsy tests for early cancer dete......
31.07.24 - 14:48
 BioMark Diagnostics, Inc.: The U.S. Patent and Trademark Office Grants BioMark Patent That Expands Its Claims Covering Its Legacy Liquid Biopsy Assay (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2024) - BioMark Diagnostics Inc., (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), a leading developer of liquid biopsy......
15.07.24 - 14:48
 BioMark Diagnostics, Inc.: BioMark Diagnostics Announces Presentation of Promising Glioblastoma Research at 2024 GPEN Conference (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - July 15, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), a leading developer of liquid biopsy ......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Im Winter beim Ofen, im Sommer im Feld. - Bauernregel - Bauernweisheit
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!